Our Pricing

Senset Weight Loss Treatment UK

Published on: June 03, 2026

Searching for senset weight loss treatment uk options? At Cured Pharmacy, our UK-registered clinical team offers comprehensive weight loss consultations with access to MHRA-licensed treatments including GLP-1 injections and fat absorption inhibitors, all with transparent upfront pricing and discreet delivery across the UK.

Understanding Prescription Weight Loss Treatments in the UK

The UK pharmaceutical landscape has transformed significantly with the introduction of GLP-1 receptor agonists alongside established fat absorption inhibitors. All prescription weight loss medications available through UK pharmacies require clinical assessment by a registered prescriber to ensure safety and suitability [1].

Modern weight loss treatments work through distinct mechanisms: GLP-1 medications like tirzepatide and semaglutide regulate appetite and blood sugar by mimicking natural hormones, whilst orlistat-based treatments prevent approximately 30% of dietary fat absorption in the digestive system [2]. Your UK prescriber will determine which approach aligns with your medical history, current health status, and weight loss goals.

GLP-1 Receptor Agonists: The Gold Standard for Weight Loss

Tirzepatide represents the most advanced development in weight management, functioning as the first dual GIP/GLP-1 receptor agonist licensed by the MHRA. In the SURMOUNT-1 trial, participants achieved an average body weight reduction of 20.9% over 72 weeks on the highest dose, significantly outperforming single-pathway alternatives [3].

Semaglutide, available in both injectable and oral formulations, demonstrated consistent efficacy in the STEP clinical trial programme. Participants in STEP 1 achieved an average 14.9% body weight reduction over 68 weeks, with 86.4% of participants losing at least 5% of their baseline weight [4]. Both medications require once-weekly administration and are initiated at low doses to minimise gastrointestinal side effects.

Comparing Injectable GLP-1 Options

Mounjaro, Wegovy, and Saxenda all belong to the GLP-1 class but differ in potency, dosing frequency, and clinical outcomes. Mounjaro's dual-receptor mechanism typically produces greater weight reduction than single-pathway alternatives, whilst Saxenda requires daily rather than weekly injections. Your UK prescriber will consider your lifestyle, tolerance for injections, and medical history when recommending the most appropriate option.

Orlistat-Based Treatments: Fat Absorption Inhibitors

Orlistat works through a completely different mechanism by inhibiting pancreatic and gastric lipases, enzymes responsible for breaking down dietary fats. This prevents approximately 25-30% of consumed fat from being absorbed, with unabsorbed fat eliminated through bowel movements [5].

Available in both 120mg prescription strength and 60mg over-the-counter formulations, orlistat-based treatments require commitment to a reduced-fat diet to minimise gastrointestinal side effects. Clinical trials demonstrated an average additional weight loss of 2.9kg compared to diet and exercise alone over 12 months [5]. Orlistat remains a cost-effective option for patients who prefer oral medication over injections.

Prescription vs Over-the-Counter Orlistat

Prescription-strength orlistat at 120mg delivers higher potency than 60mg over-the-counter alternatives, but both formulations require clinical assessment at Cured Pharmacy. The higher dose may produce more pronounced effects but also carries increased risk of gastrointestinal side effects if dietary fat intake isn't carefully managed. Your prescriber will recommend the appropriate strength based on your BMI and weight loss objectives.

Clinical Assessment Process at Cured Pharmacy

Every prescription weight loss treatment dispensed through Cured Pharmacy requires completion of a comprehensive online clinical assessment reviewed by UK-registered prescribers. This typically takes under three minutes and covers your medical history, current medications, weight loss goals, and any contraindications [6].

Our superintendent pharmacist Tarun Kumar (GPhC 2233073) oversees all clinical protocols to ensure compliance with MHRA and NICE guidelines. The assessment determines not only whether you're suitable for weight loss medication, but which specific treatment and dosage offers the optimal balance of efficacy and safety for your individual circumstances. All consultations are provided free of charge, with transparent pricing displayed before you begin.

Managing Side Effects and Treatment Expectations

GLP-1 medications commonly produce gastrointestinal side effects including nausea, diarrhoea, and constipation, particularly during dose escalation phases. These effects typically diminish within 4-8 weeks as your body adapts to the medication [7]. Starting at low doses and increasing gradually significantly reduces symptom severity.

Orlistat-based treatments may cause oily stools, increased bowel frequency, and faecal urgency if dietary fat intake exceeds recommended levels. These effects serve as a behavioural reinforcement mechanism, encouraging adherence to a reduced-fat diet. Regardless of which treatment your prescriber recommends, realistic expectations are essential: prescription medications enhance but don't replace dietary modification and increased physical activity.

Clinical trials demonstrate that combining pharmacotherapy with lifestyle interventions produces superior outcomes compared to either approach alone. Your prescriber may recommend nutritional counselling or structured exercise programmes alongside medication to optimise results and establish sustainable long-term habits [1].

When to Contact Your Prescriber

Whilst mild side effects are expected and manageable, certain symptoms warrant immediate clinical review. Contact your prescriber if you experience severe abdominal pain, persistent vomiting preventing fluid intake, signs of pancreatitis, or allergic reactions. Regular follow-up assessments ensure your treatment remains appropriate as your weight and health status evolve throughout your weight loss journey.

Why Choose Cured Pharmacy for Weight Loss Treatment

As a fully registered UK pharmacy (GPhC 9012511), Cured Pharmacy dispenses only genuine MHRA-licensed medications sourced through legitimate UK supply chains. Our transparent pricing model displays exact costs before you complete your clinical assessment, eliminating hidden fees or unexpected charges common with other providers.

We guarantee the lowest prices in the UK for prescription weight loss treatments, with discreet packaging and prompt delivery across England, Scotland, Wales, and Northern Ireland. Our UK-based clinical team provides ongoing support throughout your treatment, with prescription renewals and dose adjustments handled seamlessly through your online account. Every medication is dispensed by qualified pharmacists under the supervision of our superintendent pharmacist, ensuring the highest standards of pharmaceutical care.

Scientific References

1. National Institute for Health and Care Excellence. (2023). Obesity: identification, assessment and management (CG189). NICE. [accessed 13 August 2026]
2. Torgerson, J. S., et al. (2004). XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients. Diabetes Care, 27(1), 155-161. [accessed 13 August 2026]
3. Jastreboff, A. M., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205-216. [accessed 13 August 2026]
4. Wilding, J. P. H., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989-1002. [accessed 13 August 2026]
5. Rucker, D., et al. (2007). Long term pharmacotherapy for obesity and overweight: updated meta-analysis. British Medical Journal, 335(7631), 1194-1199. [accessed 13 August 2026]
6. Medicines and Healthcare products Regulatory Agency. (2023). Patient Group Directions for weight management services. MHRA. [accessed 13 August 2026]
7. Nauck, M. A., et al. (2021). GLP-1 receptor agonists in the treatment of type 2 diabetes – state-of-the-art. Molecular Metabolism, 46, 101102. [accessed 13 August 2026]

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication.